(Q30492745)

12 October 2017

Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting (English)

1 reference

cost-effectiveness analysis

12 October 2017

1 reference

1 reference

Marcus A Neubauer

1

1 reference

12 October 2017

J Russell Hoverman

2

1 reference

12 October 2017

Michael Kolodziej

3

1 reference

12 October 2017

Lonny Reisman

4

1 reference

12 October 2017

Stephen K Gruschkus

5

1 reference

12 October 2017

Susan Hoang

6

1 reference

12 October 2017

Albert A Alva

7

1 reference

12 October 2017

Marilyn McArthur

8

1 reference

12 October 2017

Michael Forsyth

9

1 reference

12 October 2017

Todd Rothermel

10

1 reference

12 October 2017

Roy A Beveridge

11

1 reference

12 October 2017

language of work or name

English

0 references

publication date

30 December 2009

1 reference

Journal of Oncology Practice

12 October 2017

1 reference

12 October 2017

6

1 reference

12 October 2017

1

1 reference

12 October 2017

12-18

1 reference

Pharmacoeconomic evaluations in the treatment of non-small cell lung cancer

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

Evaluating the efficiency of california providers in caring for patients with chronic illnesses

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

A propensity score approach to estimating the cost-effectiveness of medical therapies from observational data

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

Regression methods for cost-effectiveness analysis with censored data

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

Lung cancer: a cost and outcome study based on physician practice patterns

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

Health care quality, geographic variations, and the challenge of supply-sensitive care.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

Vinorelbine in advanced non-small cell lung cancer. A pharmacoeconomic review

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

Estimating medical costs from incomplete follow-up data

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

Using propensity scores to estimate the cost-effectiveness of medical therapies

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

Costs, effects and C/E-ratios alongside a clinical trial.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805337

Practice guidelines developed by specialty societies: the need for a critical appraisal

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20539725

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20539725

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1200/JOP.091058

1 reference

12 October 2017

1 reference

12 October 2017

PubMed publication ID

20539725

1 reference